The ECVAM Task Force on Integrated Testing Strategies was established in December 1996, with the remit of assessing the current status of integrated toxicity testing, and of making proposals regarding the design and implementation of integrated testing strategies. The first step in an integrated testing strategy is usually to determine the chemical functionality of a substance, on the basis of its structure and physicochemical properties. The biokinetic and dynamic behaviours of the chemical in various in vitro systems are then assessed. The various elements are then integrated, in either a parallel or a stepwise fashion, to make predictions of the local or systemic toxicity of the chemical of interest. In this report, a generic scheme for local/systemic toxicity, and a specific scheme for target organ toxicity, are proposed. The scope and limitations of the approaches are discussed. The task force hopes that its proposals will stimulate a discussion on the feasibility of this type of approach and it welcomes any feedback. It is planned that the discussion points will be elaborated in a second task force report.
BarrattM.D., CastellJ.V., ChamberlainM., CombesR.D., DeardenJ.C., FentemJ.H., GernerI., GiulianiA., GrayT.J.B., LivingstoneD.J., ProvanW.M., RuttenA.A.J.J.L., VerhaarH.J.M., & ZbindenP. (1995). The integrated use of alternative approaches for predicting toxic hazard. The report and recommendations of ECVAM workshop 8. ATLA23, 410–429.
2.
BlaauboerB.J., BaylissM.K., CastellJ.V., EveloC.T.A., FrazierJ.M., GroenK., GüldenM., GuillouzoA., HissinkA.M., HoustonJ.B., JohansonG., de JonghJ., KedderisG.L., ReinhardtC.A., van de SandtJ.J.M., & SeminoG. (1996). The use of biokinetics and in vitro methods in toxicological risk evaluation. The report and recommendations of ECVAM workshop 15. ATLA24, 473–497.
3.
SeibertH., BallsM., FentemJ.H., BianchiV., ClothierR.H., DierickxP.J., EkwallB., GarleM.J., Gómez-LechónM.J., GribaldoL., GüldenM., LiebschM., RasmussenE., RoguetR., ShrivastavaR., & WalumE. (1996). Acute toxicity testing in vitro and the classification and labelling of chemicals. The report and recommendations of ECVAM workshop 16. ATLA24, 499–510.
4.
LeahyD.E., DuncanR., AhrH.J., BaylissM.K., de BoerA.G., DarvasF., FentemJ.H., FryJ.R., HopkinsR., HoustonJ.B., KarlssonJ., KedderisG.L., PrattenM.K., PrietoP., SmithD.A., & StraughanD.W. (1997). Pharmacokinetics in early drug research. The report and recommendations of ECVAM workshop 22. ATLA25, 410–429.
5.
BarrattM.D., DixitM.B., & JonesP.A. (1996). The use of in vitro cytotoxicity measurements for the prediction of the skin corrosivity potential of acids: a QSAR method. Toxicology in Vitro10, 283–290.
6.
BasketterD.A., ScholesE.W., ChamberlainM., & BarrattM.D. (1995). An alternative strategy to the use of guinea-pigs for the identification of skin sensitization hazard. Food and Chemical Toxicology33, 1051–1056.
7.
WhittleE.G., BarrattM.D., CarterJ.A., BasketterD.A., & ChamberlainM. (1996). The skin corrosivity potential of fatty acids: in vitro rat and human skin testing and QSAR studies. Toxicology in Vitro10, 95–100.
8.
HermensJ.L.M. (1989). Quantitative structure-activity relationships of environmental pollutants. In Handbook of Environmental Chemistry, Vol. 2E (ed. HutzingerO.), pp. 111–162. Berlin, Germany: Springer-Verlag.
9.
BarrattM.D. (1996). Quantitative structure-activity relationships (QSARs) for skin corrosivity of organic acids, bases and phenols: principal components and neural network analysis of extended datasets. Toxicology in Vitro10, 85–94.
10.
ClemedsonC. (1996). MEIC evaluation of acute systemic toxicity. I. Methodology of 68 in vitro toxicity assays used to test the first 30 reference chemicals. ATLA24, Suppl. 1, 249–272.
11.
ClemedsonC. (1996). MEIC evaluation of acute systemic toxicity. II. In vitro results from 68 toxicity assays used to test the first 30 reference chemicals and a comparative cytotoxicity analysis. ATLA24, Suppl. 1, 273–311.
12.
ClemedsonC. (1998). MEIC evaluation of acute systemic toxicity. III. In vitro results from 16 additional methods used to test the first 30 reference chemicals and a comparative cytotoxicity analysis. ATLA26, Suppl. 1, 93–129.
13.
ClemedsonC. (1998). MEIC evaluation of acute systemic toxicity. IV. In vitro results from 67 toxicity assays used to test reference chemicals 31–50 and a comparative cytotoxicity analysis. ATLA26, Suppl. 1, 131–183.
14.
BlaauboerB.J., BallsM., BianchiV., BolcsfoldiG., GuillouzoA., MooreG.A., OdlandL., ReinhardtC.A., SpielmannH., & WalumE. (1994). The ECITTS integrated toxicity testing scheme: the application of in vitro test systems to the hazard assessment of chemicals. Toxicology in Vitro8, 845–846.
15.
WalumE., BallsM., BianchiV., BlaauboerB., BolcsfoldiG., GuillouzoA., MooreG.A., OdlandL., ReinhardtC, & SpielmannH. (1992). ECITTS: an integrated approach to the application of in vitro test systems to the hazard assessment of chemicals. ATLA20, 406–428.
16.
DeJonghJ., ForsbyA., HoustonJ.B., BeckmanM., CombesR., & BlaauboerB.J. (1999). An integrated approach to the prediction of systemic toxicity using computer-based biokinetic models and biological in vitro test methods: a prevalidation study based on the ECITTS project. Toxicology in Vitro, in press.
17.
de SilvaO., CottinM., DamiN., RoguetR, CatrouxP., TouficA., SicardC., DossouK.G., GernerI., SchledeE., SpielmannH., GuptaK.C., & HillR.N. (1997). Evaluation of eye irritation potential: statistical analysis and tier testing strategies. Food and Chemical Toxicology35, 159–164.
18.
AtterwillC.K., BruininkA., DrejerJ., DuarteE., AbdullaE.M., MeredithC., NicoteraP., ReganC., Rodríguez-FarréE., SimpsonM.G., SmithR., VeronesiB., VijverbergH., WalumE., & WilliamsD.C. (1994). In vitro neurotoxicity testing. The report and recommendations of ECVAM workshop 3. ATLA22, 350–362.
19.
KarolM.H. (1998). Target organs and systems: methodologies to assess immune system function. Environmental Health Perspectives106, Suppl. 2, 533–540.
20.
SpielmannH., LovellW.W., HölzleE., JohnsonB.E., MaurerT., MirandaM.A., PapeW.J.W., SaporaO., & SladowskiD. (1994). In vitro phototoxicity testing. The report and recommendations of ECVAM workshop 2. ATLA22, 314–348.
21.
SpielmannH., BallsM., DupuisJ., PapeW.J.W, PechovitchG., de SilvaO., HolzhütterH.G., ClothierR., DesolleP., GerberickF., LiebschM., LovellW.W., MaurerT., PfannenbeckerU., PolthastJ.M., CsatoM., SladowskiD., SteilingW., & BrantomP. (1998). The international EU/COLIPA in vitro phototoxicity validation study: results of phase II (blind trial). Part 1: the 3T3 NRU phototoxicity test. Toxicology in Vitro12, 305–327.
22.
SandersonD.M., & EarnshawC.G. (1991). Computer prediction of possible toxic action from chemical structure; the DEREK system. Human and Experimental Toxicology10, 261–273.
23.
RidingsJ.E., BarrattM.D., CaryR., EarnshawC.G., EggingtonE., EllisM.K., JudsonP.N., LangowskiJ.J., MarchantC.A., PayneM.P., WatsonW.P., & YihT.D. (1996). Computer prediction of possible toxic action from chemical structure; an update on the DEREK system. Toxicology106, 267–279.
24.
BarrattM.D. (1995). Quantitative structure-activity relationships for skin permeability. Toxicology in Vitro9, 27–37.
25.
BarrattM.D. (1996). Quantitative structure-activity relationships for skin irritation and corrosivity of neutral and electrophilic organic chemicals. Toxicology in Vitro10, 247–256.
26.
BarrattM.D. (1997). QSARs for the eye irritation potential of neutral organic chemicals. Toxicology in Vitro11, 1–8.
27.
CroninM.T., & BasketterD.A. (1994). Multivariate analysis of a skin sensitization database. SAR and QSAR in Environmental Research2, 159–179.
28.
BenigniR., AndreoliC., & GiulianiA. (1994). QSAR models for both mutagenic potency and activity: application to nitroarenes and aromatic amines. Environmental and Molecular Mutagenesis24, 208–219.
29.
BrownR.P., ForanJ., OlinS., & RobinsonD. (1994). Physiological Parameter Values for PBPK Models, 100 pp. Washington, DC, USA: International Life Sciences Institute (ILSI) Risk Science Institute (RSI).
30.
ArturrsonP., & BorchardtR. (1997). Intestinal drug absorption and metabolism in cell cultures: CaCo-2 and beyond. Pharmaceutical Research14, 1655–1660.
31.
DeJonghJ., VerhaarH.J., & HermensJ.L. (1997). A quantitative property-property relationship (QPPR) approach to estimate in vitro tissue–blood partition coefficients of organic chemicals in rats and humans. Archives of Toxicology72, 17–25.
32.
HoustonJ.B., & CarlileD.J. (1997). Incorporation of in vitro drug metabolism data into physiologically-based pharmacokinetic models. Toxicology in Vitro11, 473–478.
33.
HoustonJ.B., & CarlileD.J. (1997). Prediction of hepatic clearance from microsomes, hepatocytes and liver slices. Drug Metabolism Reviews29, 891–922.
34.
DeJonghJ., VerhaarH.J.M., & HermensJ.L.M. (1998). Role of kinetics in acute lethality of nonreactive volatile organic compounds (VOCs). Toxicological Science45, 26–32.
